Balestrieri, N., Dong, G., & Ryan, T. E. (2025). Pirfenidone treatment improves ischemic muscle function in mice with chronic kidney disease. Skeletal Muscle, 15(1), 1. https://doi.org/10.1186/s13395-025-00402-5
Chicago Style (17th ed.) CitationBalestrieri, Nicholas, Gengfu Dong, and Terence E. Ryan. "Pirfenidone Treatment Improves Ischemic Muscle Function in Mice with Chronic Kidney Disease." Skeletal Muscle 15, no. 1 (2025): 1. https://doi.org/10.1186/s13395-025-00402-5.
MLA (9th ed.) CitationBalestrieri, Nicholas, et al. "Pirfenidone Treatment Improves Ischemic Muscle Function in Mice with Chronic Kidney Disease." Skeletal Muscle, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1186/s13395-025-00402-5.
Warning: These citations may not always be 100% accurate.